Skip to content

Does high intensity intermittent exercise promote health and wellbeing in overweight and obese men?

An evaluation of low volume high-intensity intermittent training (HIIT) for health risk reduction in overweight and obese men

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ISRCTN
Registry ID
ISRCTN90672085
Enrollment
16
Registered
2017-02-22
Start date
2012-04-20
Completion date
Unknown
Last updated
2017-05-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Obesity Nutritional, Metabolic, Endocrine Obesity

Interventions

Participants are randomised to one of two groups using an online random number generator. Those in the first group (N=8) complete 6 sessions of HIIT exercise over a 2-week period where as group 2 (N=1

Sponsors

Loughborough University
Lead Sponsor

Eligibility

Sex/Gender
Male

Inclusion criteria

Inclusion criteria: 1. BMI = 27 kg·m-2 2. Reported taking part in any form of exercise less than 2 times per week 3. Otherwise healthy 4. Male

Exclusion criteria

Exclusion criteria: 1. Smokers 2. Previously diagnosed with impaired fasting glucose or diabetes 3. BMI = 40 kg.m-2

Design outcomes

Primary

MeasureTime frame
Fasting glucose is measured via an oral glucose tolerance test (OGTT) which will be performed one week prior to intervention and 72 hours immediately post the last exercise session in week two.

Secondary

MeasureTime frame
Inflammatory profile is assessed at baseline, 1 week prior to intervention and once again 72 hours post-the final exercise bout. Inflammatory profile is assessed by measuring: 1. Adiponectin, MCP-1 and CRP using commercial sandwich enzyme linked immunosorbent assays (ELISAs) 2. CRP and TNF-avia using high sensitivity ELISAs (R & D systems, Minneapolis, MN, USA) 3. Plasma IL-6 and sIL-6R via ‘in-house’ ELISAs

Countries

United Kingdom

Outcome results

None listed

Source: ISRCTN (via WHO ICTRP) · Data processed: Mar 10, 2026